CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the verona newly diagnosed type 2 diabetes study (VNDS) 3

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Trombetta, Maddalena ^a,b   Bonetti, Sara ^a   Boselli, MariaLinda ^a   Turrini, Fabiola ^a   Malerba, Giovanni ^c   Trabetti, Elisabetta ^c   Pignatti, PierFranco ^c   Bonora, Enzo ^a,b   Bonadonna, Riccardo C ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; VOLTAGE GATED CALCIUM CHANNEL; CACNA1E PROTEIN, HUMAN; CALCIUM CHANNEL R TYPE; CATION TRANSPORT PROTEIN;

ADULT; AGED; ARTICLE; CACNA1E GENE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNORADIOMETRIC ASSAY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; RISK FACTOR; STATISTICAL MODEL;

AGED; BLOOD GLUCOSE; CALCIUM CHANNELS, R-TYPE; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNORADIOMETRIC ASSAY; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LINEAR MODELS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84857950850     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032755     Document Type: Article

References (22)

1. Yang SN, Berggren PO, (2005) CaV2.3 channel and PKClambda: new players in insulin secretion. J Clin Invest 115: 16-20.
2. Williams ME, Marubio LM, Deal CR, Hans M, Brust PF, et al. (1994) Structure and functional characterization of neuronal alpha 1E calcium channel subtypes. J Biol Chem 269: 22347-22357.
3. Jing X, Li DQ, Olofsson CS, Salehi A, Surve VV, et al. (2005) CaV2.3 calcium channels control second-phase insulin release. J Clin Invest 115: 146-154.
4. Pereverzev A, Vajna R, Pfitzer G, Hescheler J, Klockner U, et al. (2002) Reduction of insulin secretion in the insulinoma cell line INS-1 by overexpression of a Ca(v)2.3 (alpha1E) calcium channel antisense cassette. Eur J Endocrinol 146: 881-889.
5. Matsuda Y, Saegusa H, Zong S, Noda T, Tanabe T, (2001) Mice lacking Ca(v)2.3 (alpha1E) calcium channel exhibit hyperglycemia. Biochem Biophys Res Commun 289: 791-795.
6. Pereverzev A, Mikhna M, Vajna R, Gissel C, Henry M, et al. (2002) Disturbances in glucose-tolerance, insulin-release, and stress-induced hyperglycemia upon disruption of the Ca(v)2.3 (alpha 1E) subunit of voltage-gated Ca(2+) channels. Mol Endocrinol 16: 884-895.
7. Muller YL, Hanson RL, Zimmerman C, Harper I, Sutherland J, et al. (2007) Variants in the Ca V 2.3 (alpha 1E) subunit of voltage-activated Ca2+ channels are associated with insulin resistance and type 2 diabetes in Pima Indians. Diabetes 56: 3089-3094.
8. Holmkvist J, Tojjar D, Almgren P, Lyssenko V, Lindgren CM, et al. (2007) Polymorphisms in the gene encoding the voltage-dependent Ca(2+) channel Ca (V)2.3 (CACNA1E) are associated with type 2 diabetes and impaired insulin secretion. Diabetologia 50: 2467-2475.
9. Bonetti S, Trombetta M, Malerba G, Boselli L, Trabetti E, et al. (2011) Variants and haplotypes of TCF7L2 are associated with beta-cell function in patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1. J Clin Endocrinol Metab 96: E389-393.
10. Bonetti S, Trombetta M, Boselli ML, Turrini F, Malerba G, et al. (2011) Variants of GCKR Affect Both {beta}-Cell and Kidney Function in Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study 2. Diabetes Care.
11. Bonadonna RC, Heise T, Arbet-Engels C, Kapitza C, Avogaro A, et al. (2010) Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. J Clin Endocrinol Metab 95: 5028-5036.
12. Cretti A, Lehtovirta M, Bonora E, Brunato B, Zenti MG, et al. (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31: 405-416.
13. Targher G, Bonadonna RC, Alberiche M, Zenere MB, Muggeo M, et al. (2001) Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. Diabetes Care 24: 1961-1966.
14. Saccomani MP, Bonadonna RC, Bier DM, DeFronzo RA, Cobelli C, (1996) A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study. Am J Physiol 270: E170-185.
15. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, et al. (2000) Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151: 190-198.
16. Cobelli C, Toffolo GM, Dalla Man C, Campioni M, Denti P, et al. (2007) Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 293: E1-E15.
17. Mari A, Camastra S, Toschi E, Giancaterini A, Gastaldelli A, et al. (2001) A model for glucose control of insulin secretion during 24 h of free living. Diabetes 50 (Suppl 1): S164-168.
18. Davidovich O, Kimmel G, Shamir R, (2007) GEVALT: an integrated software tool for genotype analysis. BMC Bioinformatics 8: 36.
19. Lin CH, Yeakley JM, McDaniel TK, Shen R, (2009) Medium- to high-throughput SNP genotyping using VeraCode microbeads. Methods Mol Biol 496: 129-142.
20. Cali AM, Bonadonna RC, Trombetta M, Weiss R, Caprio S, (2008) Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. J Clin Endocrinol Metab 93: 1767-1773.
21. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, et al. (2005) Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 54: 1735-1743.
22. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, et al. (2004) The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 21: 52-58.